Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Coghlan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|February 8, 2021
Overview of Humira® Biosimilars: Current European Landscape and Future ImplicationsJill Coghlan, Hongliang He, Anna S Schwendeman
Frontiers in Bioengineering and Biotechnology|April 1, 2022
Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed ConditionsJill Coghlan, Alexander Benet, Preethi Kumaran, et al.
Pharmaceutical Research|December 24, 2021
Research and Education Needs for Complex GenericsSydney Stern, Jill Coghlan, Vishalakshi Krishnan, et al.
Analytical Chemistry|November 22, 2021
Collision-Induced Unfolding Reveals Stability Differences in Infliximab Therapeutics under Native and Heat Stress ConditionsDaniel D Vallejo, Jukyung Kang, Jill Coghlan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 17, 2019
Multifaceted assessment of rituximab biosimilarity: The impact of glycan microheterogeneity on Fc functionJukyung Kang, Sang Yeop Kim, Daniel Vallejo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|February 8, 2021
Overview of Humira® Biosimilars: Current European Landscape and Future ImplicationsJill Coghlan, Hongliang He, Anna S Schwendeman
Frontiers in Bioengineering and Biotechnology|April 1, 2022
Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed ConditionsJill Coghlan, Alexander Benet, Preethi Kumaran, et al.
Pharmaceutical Research|December 24, 2021
Research and Education Needs for Complex GenericsSydney Stern, Jill Coghlan, Vishalakshi Krishnan, et al.
Analytical Chemistry|November 22, 2021
Collision-Induced Unfolding Reveals Stability Differences in Infliximab Therapeutics under Native and Heat Stress ConditionsDaniel D Vallejo, Jukyung Kang, Jill Coghlan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 17, 2019
Multifaceted assessment of rituximab biosimilarity: The impact of glycan microheterogeneity on Fc functionJukyung Kang, Sang Yeop Kim, Daniel Vallejo, et al.
Pageof 1